Friis, Søren

Alcohol-abuse drug disulfiram targets cancer via p97 segregase adaptor NPL4

Skrott, Z., Mistrik, M., Andersen, K. K., Friis, S., Majera, D., Gursky, J., Ozdian, T., Bartkova, J., Turi, Z., Moudry, P., et al. (2017) · Nature

Ubiquitin and proteasome pathwaysCancer-related Molecular Pathways

Cited by 807

Cancer incidence in persons with type 1 diabetes: A five-country study of 9,000 cancers in type 1 diabetic individuals

on behalf of the Diabetes and Cancer Research Consortium, Carstensen, B., Read, S. H., Friis, S., Sund, R., Keskimäki, I., Svensson, A.-M., Ljung, R., Wild, S. H., Kerssens, J. J., et al. (2016) · Diabetologia

Metabolism, Diabetes, and CancerDiabetes Management and Research

Cited by 180

Proton Pump Inhibitor Use and Risk of Colorectal Cancer: A Population-Based, Case–Control Study

Robertson, D. J., Larsson, H., Friis, S., Pedersen, L., Baron, J. A., & Sørensen, H. T. (2007) · Gastroenterology

Inflammatory mediators and NSAID effectsColorectal Cancer Screening and Detection

Cited by 139

The impact of the COVID‐19 pandemic on cancer diagnosis based on pathology notifications: A comparison across the Nordic countries during 2020

Johansson, A. L. V., Larønningen, S., Skovlund, C. W., Kristiansen, M. F., Mørch, L. S., Friis, S., Johannesen, T. B., Myklebust, T. Å., Skog, A., Pettersson, D., et al. (2022) · International Journal of Cancer

COVID-19 and healthcare impactsGlobal Cancer Incidence and Screening

Cited by 38